retention-jackjacks.blogspot.com
While their application is not yetfullu vetted, biomarkers for lung, prostate and colorectal cancer have shown correlation with significantly increaser survival. The next step, already underway, is the linkinfg of biomarker results with experimental therapies and The , and international scientifivc organizations are actively working to facilitatwe the outcome of these studies. While majore hurdles remain — the number of potential combination availabilityof agents, cost of clinical trials and a limiter number of investigators — the end resulyt promises a more personalized approach to cancer therapy, providingy opportunities to fine-tune a patient’s treatmenyt with the expectation of improved survival and ultimately a
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment